Skip to content 
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified. more
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | -2.34% | -0.85% |
| 1-Month Return | 6.77% | 0.26% |
| 3-Month Return | 12.8% | 5.19% |
| 6-Month Return | 1.79% | 8.57% |
| 1-Year Return | 38.79% | 19.02% |
| 3-Year Return | 24.39% | 64.83% |
| 5-Year Return | -25.66% | 71.8% |
| 10-Year Return | 61.87% | 245.09% |
| Stock name | Ticker | Weight |
|---|---|---|
 GUARDANT HEALTH INC | GH | 9.54% |
 NATERA INC | NTRA | 7.53% |
 KRYSTAL BIOTECH INC | KRYS | 5.91% |
 LIGAND PHARMACEUTICALS | LGND | 4.4% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 4.17% |
 BRIDGEBIO PHARMA INC | BBIO | 3.83% |
 UNITED THERAPEUTICS CORP | UTHR | 3.48% |
 ELI LILLY & CO | LLY | 2.92% |
 VERTEX PHARMACEUTICALS IN | VRTX | 2.73% |
 TWIST BIOSCIENCE CORP | TWST | 2.57% |
 TRAVERE THERAPEUTICS INC | TVTX | 2.56% |
 INSMED INC | INSM | 2.5% |
 ASTRAZENECA PLC | AZN.L | 2.45% |
 SAMSUNG BIOLOGICS CO LTD | 207940.KS | 2.41% |
 CORTEVA INC | CTVA | 2.34% |
 MEDPACE HOLDINGS INC | MEDP | 2.21% |
 CASH | CASH | 2.1% |
 REGENERON PHARMACEUTICALS | REGN | 1.99% |
 NEUROCRINE BIOSCIENCES IN | NBIX | 1.91% |
 ALNYLAM PHARMACEUTICALS I | ALNY | 1.87% |
 TEMPUS AI INC-CL A | TEM | 1.83% |
 VERACYTE INC | VCYT | 1.68% |
 ARGENX SE | ARGX.BR | 1.54% |
 PTC THERAPEUTICS INC | PTCT | 1.43% |
 BIONTECH SE-ADR | BNTX | 1.38% |
 IONIS PHARMACEUTICALS INC | IONS | 1.34% |
 CHARLES RIVER LABORATORIE | CRL | 1.3% |
 STOKE THERAPEUTICS INC | STOK | 1.2% |
 CAREDX INC | CDNA | 1.17% |
 GRAIL INC | GRAL | 1.17% |
 REPLIGEN CORP | RGEN | 1.08% |
 CADENCE DESIGN SYS INC | CDNS | 0.96% |
 SARTORIUS AG-VORZUG | SRT3.DE | 0.93% |
 CRISPR THERAPEUTICS AG | CRSP | 0.89% |
 ANAPTYSBIO INC | ANAB | 0.84% |
 THERMO FISHER SCIENTIFIC | TMO | 0.83% |
 IQVIA HOLDINGS INC | IQV | 0.83% |
 AXSOME THERAPEUTICS INC | AXSM | 0.81% |
 PRAXIS PRECISION MEDICINE | PRAX | 0.8% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 0.8% |
 BEAM THERAPEUTICS INC | BEAM | 0.78% |
 HINGE HEALTH INC-A | HNGE | 0.73% |
 DANAHER CORP | DHR | 0.63% |
 AGILENT TECHNOLOGIES INC | A | 0.6% |
 ULTRAGENYX PHARMACEUTICAL | RARE | 0.56% |
 QIAGEN N.V. | QIA.DE | 0.52% |
 ARCUTIS BIOTHERAPEUTICS I | ARQT | 0.45% |
 RHYTHM PHARMACEUTICALS IN | RYTM | 0.4% |
 FIRST TRACKS BIOTHERAPEUT | TRAX | 0.37% |
 SAMSUNG EPISHOLDINGS CO L | 0126Z0.KS | 0.36% |
 KINIKSA PHARMACEUTICALS I | KNSA | 0.33% |
 BIO-RAD LABORATORIES-A | BIO | 0.27% |
 BRISTOL-MYERS SQUIBB CO | BMY | 0.26% |
 NEUROGENE INC | NGNE | 0.26% |
 BEONE MEDICINES LTD-ADR | ONC | 0.26% |
 TG THERAPEUTICS INC | TGTX | 0.25% |
 LIQUIDIA CORP | LQDA | 0.24% |
 TARSUS PHARMACEUTICALS IN | TARS | 0.24% |
 GENEDX HOLDINGS CORP | WGS | 0.13% |
 WAVE LIFE SCIENCES LTD | WVE | 0.1% |
 RECURSION PHARMACEUTICALS | RXRX | 0.06% |
 OMNIAB INC - 15.00 EARNOU | 2200964 | 0% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 Net Current Assets | Net.Current.Assets | -0.02% |
| Sector | Weight |
|---|---|
|
Health care | 96.63% |
|
Materials | 2.39% |
|
Information Technology | 0.98% |
Franklin Genomic Advancements ETF (HELX) share price today is $38.744.
Yes, Indians can buy shares of Franklin Genomic Advancements ETF (HELX) on Vested. To buy HELX from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Franklin Genomic Advancements ETF (HELX) on Vested. You can start investing in Franklin Genomic Advancements ETF (HELX) with a minimum investment of $1.
The 52-week high price of Franklin Genomic Advancements ETF (HELX) is $41.3. The 52-week low price of Franklin Genomic Advancements ETF (HELX) is $27.43.
The stock symbol (or ticker) of Franklin Genomic Advancements ETF is HELX.
Yes, you can setup SIP in Franklin Genomic Advancements ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of HELX on the Vested app.
The expense ratio of Franklin Genomic Advancements ETF (HELX) is 0.5%.
Link copied 
